Adicet Bio, Inc.

ACET

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001720580

SEC filings (opens in a new tab)

No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Adicet Bio, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of ACET: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	88	3	101	+16
Shares	33.1M	54.1K	38.0M	+4.95M (+15.0%)
Value	$660.4M	$1.08M	$555.9M	−$103.5M (−15.7%)

3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Adicet Bio, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to ACET in Q2 2022
Institution	Shares	Value	% of portfolio
Candriam Luxembourg S.C.A.	1,283,582	$18.7M	0.15%
Deep Track Capital, LP	892,028	$13.0M	0.90%
Assenagon Asset Management S.A.	874,740	$12.8M	0.05%
Millennium Management LLC	128,666	$1.88M	0.00%
Renaissance Technologies LLC	125,500	$1.83M	0.00%
Healthcare of Ontario Pension Plan Trust Fund	104,900	$1.53M	0.01%
Jackson Creek Investment Advisors LLC	54,425	$919.0K	0.37%
Russell Investments Group, Ltd.	51,007	$743.0K	0.00%
Swiss National Bank	42,300	$618.0K	0.00%
Marshall Wace, LLP	32,194	$470.0K	0.00%
Telemetry Investments, L.L.C.	26,500	$387.0K	0.59%
Alps Advisors Inc	23,735	$347.0K	0.00%
Victory Capital Management Inc	23,106	$337.0K	0.00%
Graham Capital Management, L.P.	20,890	$304.0K	0.01%
Panagora Asset Management Inc	16,805	$245.0K	0.00%
Engineers Gate Manager LP	16,760	$245.0K	0.01%
Algert Global LLC	16,610	$243.0K	0.02%
Group One Trading, L.P.	15,000	$219.0K	0.01%
Credit Suisse AG	13,910	$203.0K	0.00%
Alliancebernstein L.P.	12,900	$188.0K	0.00%
Atom Investors LP	11,772	$172.0K	0.08%
SG Americas Securities, LLC	10,989	$160.0K	0.00%
Trexquant Investment LP	10,962	$160.0K	0.01%
Susquehanna International Group, LLP	10,905	$159.0K	0.00%
Voya Investment Management LLC	10,741	$157.0K	0.00%
UBS Asset Management Americas Inc	10,500	$153.3K	0.00%
Lazard Asset Management LLC	5,669	$82.0K	0.00%
Allspring Global Investments Holdings, LLC	501	$7.00K	0.00%
American Portfolios Advisors	350	$5.11K	0.00%
Crewe Advisors LLC	175	$3.00K	0.00%
Signaturefd, LLC	48	$1.00K	0.00%
Lindbrook Capital, LLC	18	$0	0.00%

Sold out (16)

Institutions that held Adicet Bio, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of ACET in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Avidity Partners Management LP	3,120,000	$62.3M
Kingdon Capital Management, L.L.C.	275,000	$5.49M
Woodline Partners LP	196,504	$3.92M
EAM Investors, LLC	131,770	$2.63M
Invesco Ltd.	103,423	$2.06M
EAM Global Investors LLC	92,202	$1.84M
Pura Vida Investments, LLC	66,626	$1.33M
State of Wisconsin Investment Board	28,000	$559.0K
J. Goldman & Co LP	19,650	$392.0K
Nisa Investment Advisors, LLC	14,800	$296.0K
Dorsey Wright & Associates	3,495	$70.0K
Simplex Trading, LLC	1,224	$24.0K
UBS Group AG	547	$11.0K
Money Concepts Capital Corp	142	$3.00K
US Bancorp	77	$2.00K
Toronto Dominion Bank	2	$0

Not filed for Q2 2022 yet (3)

Institutions that held Adicet Bio, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ACET in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Golden State Equity Partners	30,014	$599.0K
Parametric Portfolio Associates LLC	21,547	$430.0K
Amalgamated Financial Corp.	2,529	$51.0K